FRAN CRAWFORD

Chief Executive Officer, Somaserve

Fran Crawford is a serial entrepreneur who has been closely involved in the growth of several life science businesses including Altacor (ophthalmology) as founder, Spirogen (oncology) and Sirus Pharmaceuticals (CNS). Currently she has co-founded and is leading as CEO, Somaserve a UCL spin-out . Somaserve is pioneering the development of targeted nanomedicines which penetrate biological barriers using the proprietary polyNaut technology.

Fran is a PhD clinical pharmacologist who, following two post-doctoral posts entered the pharmaceutical industry in clinical research. Holding senior posts in several start-up businesses she built IP portfolios to add value and protection to product pipelines. For ten years she was responsible for growing hospital and retail sales teams to commercialise products in a Specialty Pharma setting. She has driven and participated in many funding rounds, M&A and in creating exits for the benefit of shareholders and investors.